Department of Nuclear Medicine and PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, 310009, Zhejiang, China.
Institute of Nuclear Medicine and Molecular Imaging of Zhejiang University, Hangzhou, China.
Eur J Nucl Med Mol Imaging. 2021 Jul;48(8):2338-2350. doi: 10.1007/s00259-021-05234-1. Epub 2021 Feb 13.
Pathology is the medical specialty concerned with the study of the disease nature and causes, playing a key role in bridging basic researches and clinical medicine. In the course of development, pathology has significantly expanded our understanding of disease, and exerted enormous impact on the management of patients. However, challenges facing pathology, the inherent invasiveness of pathological practice and the persistent concerns on the sample representativeness, constitute its limitations. Molecular imaging is a noninvasive technique to visualize, characterize, and measure biological processes at the molecular level in living subjects. With the continuous development of equipment and probes, molecular imaging has enabled an increasingly precise evaluation of pathophysiological changes. A new pathophysiology visualization system based on molecular imaging is forming and shows the great potential to reform the pathological practice. Several improvements in "trans-," including trans-scale, transparency, and translation, would be driven by this new kind of pathological practice. Pathological changes could be evaluated in a trans-scale imaging mode; tissues could be transparentized to better present the underlying pathophysiological information; and the translational processes of basic research to the clinical practice would be better facilitated. Thus, transpathology would greatly facilitate in deciphering the pathophysiological events in a multiscale perspective, and supporting the precision medicine in the future.
病理学是一门医学专业,主要研究疾病的性质和病因,在连接基础研究和临床医学方面发挥着关键作用。在发展过程中,病理学极大地扩展了我们对疾病的认识,并对患者的管理产生了巨大影响。然而,病理学面临的挑战、病理实践的固有侵袭性以及对样本代表性的持续关注,构成了其局限性。分子影像学是一种非侵入性技术,可在活体中可视化、表征和测量分子水平的生物学过程。随着设备和探针的不断发展,分子影像学能够对病理生理变化进行越来越精确的评估。一个基于分子影像学的新的病理生理学可视化系统正在形成,并显示出改革病理实践的巨大潜力。这种新的病理实践将推动“跨”的几个改进,包括跨尺度、透明性和转化。可以通过这种新的病理实践以跨尺度成像模式来评估病理变化;可以使组织透明化,以更好地呈现潜在的病理生理信息;并更好地促进基础研究向临床实践的转化过程。因此,跨病理学将极大地促进从多尺度角度解读病理生理事件,并为未来的精准医学提供支持。